The role of IL-33 in Severity of Systemic Sclerosis

Serum Level of Programmed Death Ligand1 in Alopecia Areata Patients in Relation to Disease Severity

Evaluation of Serum Programmed Cell Death–1 (PD-1) in Psoriasis Vulgaris: A Case-control Study

Platelet Derived Growth Factor And The Extent Of Skin Thickening As Potential Indicators Of Pulmonary Affection In Systemic Sclerosis

Prognostic Value of Soluble Programmed Death Ligand-1 (sPD-L1) in Hepatocellular Carcinoma

Interleukin-33 in systemic sclerosis: correlation with clinical manifestations and disease subset

Prognostic Value of Programed Cell Death-1 Ligand Expression in Colorectal Cancer and Its Correlation with Cytotoxic Tumor-Infiltrating Lymphocytes

Serum levels of soluble CD95 in patients with systemic lupus erythematosus

T-cell markers in systemic lupus erythromatosus patients

Detection of Macrophage Colony Stimulating Factor in Systemic Lupus Erythematosus Patients and its Relation to Disease Activity and Severity